Cover Image

Does vaccination with 4CMenB convey protection against meningococcal serogroup B strains not predicted to be covered by MATS? A study of the UK clonal complex cc269

The Meningococcal Antigen Typing System (MATS) has been developed as an hSBA surrogate to evaluate potential coverage afforded by the 4-component meningococcal serogroup B vaccine (4CMenB: Bexsero, GSK). We investigated whether the lower value of MATS coverage among invasive Meningococcus serogroup...

Full description

Saved in:

Bibliographic Details
Main Authors:	Maria Stella (Author), Maria Giuliani (Author), Alessia Biolchi (Author), Sara Tomei (Author), Rosita De Paola (Author), Xilian Bai (Author), Ray Borrow (Author), Jay Lucidarme (Author), Rita La Gaetana (Author), Daniela Toneatto (Author), Mariagrazia Pizza (Author), Laura Serino (Author), Elena Mori (Author), Marzia Monica Giuliani (Author)
Format:	Book
Published:	Taylor & Francis Group, 2020-04-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Evaluation of strain coverage of the multicomponent meningococcal serogroup B vaccine (4CMenB) administered in infants according to different immunisation schedules
by: Alessia Biolchi, et al.
Published: (2019)

Cross-reactivity of 4CMenB vaccine-induced antibodies against meningococci belonging to non-B serogroups in Italy
by: Cecilia Fazio, et al.
Published: (2021)

Evolution of strain coverage by the multicomponent meningococcal serogroup B vaccine (4CMenB) in France
by: Eva Hong, et al.
Published: (2021)

4CMenB journey to the 10-year anniversary and beyond
by: Véronique Abitbol, et al.
Published: (2024)

Bactericidal killing of meningococcal W strains isolated in Argentina by the sera of adolescents and infants immunized with 4-component meningococcal serogroup B vaccine (4CMenB)
by: Adriana Efron, et al.
Published: (2023)

Meningococcal B vaccine (4CMenB): the journey from research to real world experience
by: Rino Rappuoli, et al.
Published: (2018)

High coverage of diverse invasive meningococcal serogroup B strains by the 4-component vaccine 4CMenB in Australia, 2007-2011: Concordant predictions between MATS and genetic MATS
by: Sarah J. Tozer, et al.
Published: (2021)

Safety and immunogenicity of co-administered meningococcal serogroup B (4CMenB) vaccine: A literature review
by: Véronique Abitbol, et al.
Published: (2023)

Genetic characterization and estimated 4CMenB vaccine strain coverage of 284 Neisseria meningitidis isolates causing invasive meningococcal disease in Argentina in 2010-2014
by: Adriana Efron, et al.
Published: (2024)

A comprehensive review of clinical and real-world safety data for the four-component serogroup B meningococcal vaccine (4CMenB)
by: Gary S. Marshall, et al.
Published: (2023)

Emerging experience with meningococcal serogroup B protein vaccines
by: Daniela Toneatto, et al.
Published: (2017)

Characteristics of YouTube videos about the meningococcal B vaccine (4CMenB)
by: Ignacio Hernández-García, et al.
Published: (2020)

Persistence of the immune response after 4CMenB vaccination, and the response to an additional booster dose in infants, children, adolescents, and young adults
by: Federico Martinón-Torres, et al.
Published: (2019)

Fever-Associated Supraventricular Tachycardia after 4CMenB Vaccination in an Infant
by: Erdem Gönüllü, et al.
Published: (2019)

Adverse reactions associated with meningococcal group B vaccine (4CMenB) in adults in special situations
by: María Fernández-Prada, et al.
Published: (2018)

An open-label randomised controlled trial evaluating the efficacy of a meningococcal serogroup B (4CMenB) vaccine on Neisseria gonorrhoeae infection in gay and bisexual men: the MenGO study protocol
by: Caroline Thng, et al.
Published: (2023)

Optimizing the timing of 4CMenB vaccination in adolescents and young adults based on immune persistence and booster response data
by: Philip S. Watson, et al.
Published: (2019)

The potential public health impact of adolescent 4CMenB vaccination on Neisseria gonorrhoeae infection in England: a modelling study
by: Katharine J. Looker, et al.
Published: (2023)

Evaluating the effectiveness of the 4CMenB vaccine against invasive meningococcal disease and gonorrhoea in an infant, child and adolescent program: protocol
by: Helen S. Marshall, et al.
Published: (2021)

Evaluación económica de la inclusión en el calendario vacunal de 4CMenB (Bexsero®) en España
by: Rafael Ruiz-Montero, et al.
Published: (2020)

Available evidence on the co-administration of the four-component meningococcal B vaccine (4CMenB) with three vaccines at the same visit among pediatric individuals
by: Paolo Bonanni, et al.
Published: (2024)

The genomic epidemiology of Neisseria meningitidis carriage from a randomised controlled trial of 4CMenB vaccination in an asymptomatic adolescent populationResearch in context
by: Lex E.X. Leong, et al.
Published: (2024)

Social and behavioral predictors of two-doses 4CMenB vaccine series among adolescents enrolled in a cluster randomized controlled trial in Australia
by: Hassen Mohammed, et al.
Published: (2022)

Differentiating vaccine reactions from invasive bacterial infections in young infants presenting to the emergency department in the 4CMenB era: a retrospective observational comparison
by: Matthew D Snape, et al.
Published: (2022)

Use of expanded Neisseria meningitidis serogroup B panels with the serum bactericidal antibody assay for the evaluation of meningococcal B vaccine effectiveness
by: Ray Borrow, et al.
Published: (2023)

Modeling the public health impact of different meningococcal vaccination strategies with 4CMenB and MenACWY versus the current toddler MenACWY National Immunization Program in Chile
by: María Gabriela Graña, et al.
Published: (2021)

Product review on the IMD serogroup B vaccine Bexsero®
by: Ala-Eddine Deghmane, et al.
Published: (2022)

Meningococcal serogroup B vaccines: Estimating breadth of coverage
by: Robert G. K. Donald, et al.
Published: (2017)

An unexpected fever post serogroup B meningococcal sepsis
by: Daniele Donà, et al.
Published: (2016)

Pneumatic conveying
by: Phillips, Ernest George, 1880-

Qualify formative processes by promoting inclusive practices: the case of B. Pascal High school
by: Arianna Giuliani
Published: (2022)

Serum bactericidal activity against circulating and reference strains of meningococcal serogroup B in the United States: A review of the strain coverage of meningococcal serogroup B (MenB) vaccines in adolescents and young adults
by: Jessica Presa, et al.
Published: (2023)

Neisseria meningitidis Serogroup X ST-5799 (ST-22 complex) in Turkey: A unique pediatric case
by: Gönül Tanır, et al.
Published: (2018)

Parental awareness and utilization of meningococcal serogroup B vaccines in the United States
by: Amit Srivastava, et al.
Published: (2020)

Meningococcal serogroup B vaccine: Knowledge and acceptability among parents in Italy
by: Teresa Morrone, et al.
Published: (2017)

Protecting UK adolescents and adults against meningococcal serogroup B disease
by: Andrew Vyse, et al.
Published: (2018)

Optimal use of meningococcal serogroup B vaccines: moving beyond outbreak control
by: Paul Balmer, et al.
Published: (2018)

Isolation of Invasive Strains of Neisseria meningitides, Serogroups B and Y, in Cumana, 2009-2010
by: Dianny Martínez, et al.
Published: (2012)

Exploring the sequence diversity and surface expression of Factor H-Binding Protein among invasive serogroup B meningococcal strains from selected European countries
by: Stephen A. Clark, et al.
Published: (2024)

Proceedings of the Expert Consensus Group meeting on meningococcal serogroup B disease burden and prevention in India
by: Anand P. Dubey, et al.
Published: (2022)